Clinical trials
Lung Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
131 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 10 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 13 |
| 2020 | 15 |
| 2021 | 13 |
| 2022 | 9 |
| 2023 | 17 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 131 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Cancer Hospital and Research Institute | 5 |
| Assiut University | 3 |
| Chinese PLA General Hospital | 3 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 3 |
| Rabin Medical Center | 3 |
| Royal Brompton & Harefield NHS Foundation Trust | 3 |
| Hacettepe University | 2 |
| The University of Queensland | 2 |
| Universidad de Granada | 2 |
| ASP Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 131 |
| Lung Neoplasms | 18 |
| Pulmonary Disease, Chronic Obstructive | 17 |
| Respiratory Tract Diseases | 17 |
| Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Thoracic Neoplasms | 9 |
| Asthma | 7 |
| Pneumonia | 7 |
| Carcinoma, Bronchogenic | 6 |
Trials
Showing 76 to 100 of 131. Each trial links to its page on Pharma Observatory.
31 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.